Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Week 5 - Cardiology > Heart Failure and therapeutics > Flashcards

Heart Failure and therapeutics Flashcards

1
Q

What is the definition of heart failure?

A
  • Failure of the heart to pump blood at a rate sufficient to meet the metabolic requirements of the tissues
  • Caused by an abnormality of any aspect of cardiac function and with adequate filling pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is heart failure characterised by?

A

Typical haemodynamic changes (e.g. systemic vasoconstriction) and neurohumoral activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the common causes of heart failure in the UK?

A
  • Corornary artery disease
  • Hypertension
  • Idiopathic as in unknown
  • Toxins (alcohol, chemotherapy)
  • Genetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the causes of heart failure which are less common in the UK

A
  • Valve disease
  • Infections (virus, Chaga’s)
  • Congenital heart disease
  • Metabolic (haemochromatosis, amyloid, thyroid disease)
  • Pericardial disease (e.g. TB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 4 types of heart failure?

A
  • HF-REF (systolic HF)
  • HF-PEF (diastolic HF)
  • Chronic (congestive)
  • Acute (decompensated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the typical presentation of HF-REF

A
  • Younger
  • Male
  • Coronary aetiology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the typical presentation of HF-PEF

A
  • Older
  • More often female
  • Hypertensive aetiology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the breif overall pathology-physiology of heart failure?

A
  • Myocardial injury results in left ventricular systolic dysfunction
  • This results in perceived reduction in circulating volume and pressure
  • Resulting in neurohumoral activation (SNS, RAAS, ET and AVP, Natriuretic peptides etc. )
  • This leads to systemic vasoconstriction and the renal retention of sodium and water which then leads to further left ventricular systolic dysfunction and the cycle continues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the symptoms of heart failure?

A
  • Dyspnoea and cough
  • Ankle swelling (also legs and abdomen)
  • Fatigue/tiredness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the signs of heart failure?

A
  • Peripheral oedema (ankles, legs, sacrum and abdomen)
  • Elevated JVP
  • Third heart sound
  • Displaced apex beat
  • Pulmonary oedema (lung crackles)
  • Pleural effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the symptoms in NYHA class I

A

No symptoms and no limitation in ordinary physical activity i.e. they don’t get short of breath from walking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the symptoms in NYHA class II?

A

Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the symptoms in class III NYHA?

A

Marked limitation in activity due to symptoms, even during less than ordinary activity e.g. walking short distances
Comfortable only at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the symptoms in class IV heart failure?

A

Severe limitations. Experience symptoms even while at rest. Mostly bed bound patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What investigations should be carried out in all heart failure patients?

A
  • ECG
  • Chest X ray
  • Echocardiogram (chamber size, systolic and diastolic function, valves)
  • Blood chemistry (U+Es, Creatinine, urea, LFTs, urate)
  • Haematology (Hb, RDW)
  • Natriuretic peptides (BNP, NT-proBNP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the diagnostic algorithm for heart failure?

A
  • Suspected heart failure: risk factors/ symptoms and signs/ abnormal ECG
  • Carry out NT-proBNP or BNP. If NT-proBNP is equal to or higher than 125 pg/mL or BNP is equal to or greater than 35pg/mL then carry out echocardiography
  • If abnormal findings then heart failure is confirmed, carry on to find the HF phenotype
17
Q

How can you define the heart failure phenotype?

A
  • LVEF measurement
  • If =/<40% it is HFREF (reduced ejection fraction)
  • If 41-49% then HFMREF (mildly reduced)
  • If =/>50% then HFPEF (preserved)
18
Q

What is the treatment of HFrEF?

A
  • ACEi or ARNI
  • Beta blocker
  • MRA
  • Dapagliflozin or empagliflozin
  • Loop diuretic for fluid retention
19
Q

What medications should be given to all HF patients as stated in the ESC HFA guidelines?

A
  • ACEi or APRN
  • Beta blocker
  • MRA (aldosterone receptor antagonist)
  • SGLT2i
20
Q

What is the effect of angiotensin II on the blood vessels?

A
  • Vasoconstriction
  • smooth muscle cell hypertrophy
  • Superoxide generation
  • endothelial secretion
  • Monocyte activation
  • inflammatory cytokines
  • Reduced fibrinolysis
21
Q

What is the effect of angiotensin II in the kidney?

A
  • Sodium and water retention
  • Efferent arteriolar vasoconstriction
  • Glomerular and interstitial fibrosis
22
Q

What is the effect of angiotensin II on the heart?

A
  • cellular hypertrophy
  • myocyte apoptosis
  • Myocardial fibrosis
  • Inflammatory cytokines
  • Coronary vasoconstriction
  • Positive inotropy (strengthened heart contractions)
  • Proarrhythmia
23
Q

What is the effect of angiotensin II on the adrenal gland?

A

Aldosterone secretion

24
Q

What is the effect of angiotensin II on the brain?

A
  • Vasopressin secretion

* Sympathetic activation

25
Q

Describe the action of the ARNI LCZ696

A

ARNI= Angiotensin receptor Neprilysin Inhibition
•It combines valsartan and sacubitril
•Valsartan is a AT1 antagonist, Redding vasoconstriction, sodium/water retention and fibrosis/hypertrophy
•Sacubitril is a neprilysin antagonist. Neprilysin degrades natriuretic peptides. Sacubitril results in increased NTPs resulting in vasodilation, natriuresis, diuresis and inhibition of pathologic growth/fibrosis

26
Q

Give two examples of SGLT2is

A
  • Dapagliflozin

* Empagliflozin

26
Q

Give two examples of SGLT2is

A
  • Dapagliflozin

* Empagliflozin

27
Q

What are the devices that can be used in heart failure?

A

•ICD- implantable cardioverted defibrillator

28
Q

What are the devices that can be used in heart failure?

A

•ICD- implantable cardioverted defibrillator

29
Q

Describe biventricular/multi site pacing (or cardiac resynchronization therapy)

A
  • 3 leads
  • One in the right atrium
  • One in the right ventricle
  • Lead through the coronary sinus to the left ventricle (this makes it different to a normal pace maker)
30
Q

Who qualifies for CRT-D and CRT-P?

A
  • Anyone with a QRS over 150ms, CRT-P for class IV, option of either for class III
  • QRS 120-149 and LBBB NYHA class II-IV, CRT-p if class IV, option of either in class III
  • QRS 120-149 no LBBB, NYHA class IV CRT-P
31
Q

What can be used to inhibit the sinus node?

A

Ivabradine (slows the rate)

32
Q

What can Ivabradine be used to treat?

A

Systolic heart failure

33
Q

What drugs can be used in African Americans with heart failure?

A

Hydralazine and isosorbide dinitrate

34
Q

What drugs have the best evidence base for the treatment of heart failure with a midly reduced ejection fraction?

A

Diuretics

35
Q

Describe the management of acute heart failure

A
  • Aqua Natriuresis: Ultrafiltration
  • Arterial vasodilation: nitrates/dobutamine/nitroprusside
  • Venodilation: nitrates/morphine
  • Natriuresis: Furosemide
  • Increased inotropy: Dobutamine, dopamine, milrinone
  • Preload reduction: bilevel or continuous positive airway pressure

Week 5 - Cardiology (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions